Femtobiomed Inc. (XKON: 327610)
7,070.00
+10.00 (0.14%)
Sep 10, 2024, 9:00 AM KST
Femtobiomed Statistics
Total Valuation
Femtobiomed has a market cap or net worth of KRW 58.40 billion.
Market Cap | 58.40B |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Femtobiomed has 8.26 million shares outstanding.
Shares Outstanding | 8.26M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 47.60% |
Owned by Institutions (%) | 4.70% |
Float | 3.84M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.33% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -4.33% |
50-Day Moving Average | 7,359.80 |
200-Day Moving Average | 7,635.85 |
Relative Strength Index (RSI) | 48.21 |
Average Volume (20 Days) | 2,644 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Femtobiomed does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on July 22, 2021. It was a forward split with a ratio of 1.5.
Last Split Date | Jul 22, 2021 |
Split Type | Forward |
Split Ratio | 1.5 |